Manuel Castellón Leal

Private Equity Investor bei Cross Road Biotech Inversiones Biotecnológicas SGEIC SA

Consumer Services

Finance

Health Technology

Profil

Mr. Manuel Castellón Leal is a Founding Partner & Legal Advisor at Cross Road Biotech Inversiones Biotecnológicas SGEIC SA. Mr. Castellón Leal also served on the board at Traslational Cancer Drugs Pharma SL.
He received his undergraduate degree from Universidad Complutense de Madrid and a graduate degree from the Instituto de Empresa SL.

Aktive Positionen von Manuel Castellón Leal

Unternehmen	Position	Beginn
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA Cross Road Biotech Inversiones Biotecnológicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas SGEIC SA (Cross Road Biotech Inversiones Biotecnologicas) is a venture capital firm founded in 2001 by Enrique Castellon Leal. The firm is headquartered in Madrid, Spain.	Private Equity Investor	01.01.2001

Alle aktiven Positionen von Manuel Castellón Leal

Ehemalige bekannte Positionen von Manuel Castellón Leal

Unternehmen	Position	Ende
Traslational Cancer Drugs Pharma SL Traslational Cancer Drugs Pharma SL BiotechnologyHealth Technology Traslational Cancer Drugs Pharma SL engages in the discovery and development of therapeutic solutions for the treatment of cancer. Its TCD-717 choline kinase alpha inhibitor is an intravenously-administered small molecule designed to target cancer cells. It also provides technology in-licensing and out-licensing services. The company was founded by Juan Carlos San Juan on July 29, 2005 and is headquartered in Valladolid, Spain.	Direktor/Vorstandsmitglied	-

Sehen Sie sich die Erfahrung von Manuel Castellón Leal im Detail an

Ausbildung von Manuel Castellón Leal

Universidad Complutense de Madrid	Undergraduate Degree
Instituto de Empresa SL	Graduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Manuel Castellón Leal im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA Cross Road Biotech Inversiones Biotecnológicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas SGEIC SA (Cross Road Biotech Inversiones Biotecnologicas) is a venture capital firm founded in 2001 by Enrique Castellon Leal. The firm is headquartered in Madrid, Spain.	Finance
Traslational Cancer Drugs Pharma SL Traslational Cancer Drugs Pharma SL BiotechnologyHealth Technology Traslational Cancer Drugs Pharma SL engages in the discovery and development of therapeutic solutions for the treatment of cancer. Its TCD-717 choline kinase alpha inhibitor is an intravenously-administered small molecule designed to target cancer cells. It also provides technology in-licensing and out-licensing services. The company was founded by Juan Carlos San Juan on July 29, 2005 and is headquartered in Valladolid, Spain.	Health Technology